JNJ-28312141 - CAS 885692-52-4

JNJ-28312141 is an orally active CSF1R inhibitor and a FLT3 inhibitor. JNJ-28312141 is a new agent with potential therapeutic activity in acute myeloid leukemia and in settings where CSF-1-dependent macrophages and osteoclasts contribute to tumor growth and skeletal events.

Others, c-Fms

Tyrosine Kinase/Adaptors, Others

885636

C26H32N6O2

460.57

N(C(=O)C=1NC(C#N)=CN1)C2=C(C=C(C=C2)C3CCN(C(CN(C)C)=O)CC3)C=4CCCCC4

-20°C

Ice Packs

Small Compound